Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.33 |
| ▸ | TP53 | P04637 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | MLNR | O43193 | 1/20 | 0.33 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.33 |
| ▸ | EGFR | P00533 | 1/20 | 0.33 |
| ▸ | FYN | P06241 | 1/20 | 0.33 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.33 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.33 |
| ▸ | HTR1A | P08908 | 1/20 | 0.33 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.33 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.33 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1324498 | 0.98 | EPHX1 (0.46) | EPHX1CYP2D6TP53MEN1ALDH1A1 | |
| SCHEMBL1324615 | 0.93 | EPHX1 (0.41) | EPHX1CYP2D6TP53MEN1ALDH1A1 | |
| SCHEMBL1324554 | 0.91 | EPHX1 (0.39) | EPHX1CYP2D6TP53MEN1ALDH1A1 | |
| SCHEMBL17529723 | 0.91 | EPHX1 (0.44) | EPHX1CYP2D6TP53MEN1ALDH1A1 | |
| SCHEMBL1323180 | 0.91 | EPHX1 (0.39) | EPHX1CYP2D6TP53MEN1ALDH1A1 | |
| SCHEMBL1337268 | 0.89 | EPHX1 (0.43) | EPHX1CYP2D6TP53MEN1ALDH1A1 | |
| SCHEMBL11730380 | 0.89 | EPHX1 (0.43) | EPHX1CYP2D6TP53MEN1ALDH1A1 | |
| SCHEMBL1323141 | 0.89 | EPHX1 (0.43) | EPHX1CYP2D6TP53MEN1ALDH1A1 | |
| SCHEMBL17529700 | 0.89 | EPHX1 (0.43) | EPHX1CYP2D6TP53MEN1ALDH1A1 | |
| SCHEMBL1323171 | 0.84 | EPHX1 (0.46) | EPHX1CYP2D6TP53MEN1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023060377-A1 | C15 PHOSPHONIUM SALT ISOMER, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF | 万华化学集团股份有限公司 | 2023-04-20 | — | — | WO | claimed |
| WO-2022241670-A1 | PREPARATION METHOD FOR C15 PHOSPHINE SALT | 万华化学集团股份有限公司 | 2022-11-24 | — | — | WO | claimed |
| CN-112574388-B | Preparation method of polyisocyanate containing uretdione group | 万华化学集团股份有限公司 | 2022-07-12 | — | — | CN | claimed |
| CN-113735902-A | C15 phosphine salt isomer and preparation method and application thereof | 万华化学集团股份有限公司 | 2021-12-03 | — | — | CN | claimed |
| CN-111040101-B | Polyisocyanate having stable color number and containing uretdione group and preparation method thereof | 万华化学集团股份有限公司 | 2021-09-07 | — | — | CN | claimed |
| CN-113201016-A | Preparation method of C15 phosphonium salt | 万华化学集团股份有限公司 | 2021-08-03 | — | — | CN | claimed |
| CN-110372846-B | Preparation method of polyisocyanate with stable color value and containing uretdione group | 万华化学集团股份有限公司 | 2021-06-25 | — | — | CN | claimed |
| CN-110305294-B | Preparation method of storage-stable polyisocyanate containing uretdione group | 万华化学集团股份有限公司 | 2021-04-20 | — | — | CN | claimed |
| CN-112574388-A | Preparation method of polyisocyanate containing uretdione group | 万华化学集团股份有限公司 | 2021-03-30 | — | — | CN | claimed |
| EP-2389403-B1 | CASTINGS BASED ON POLYURETHANE | COVESTRO DEUTSCHLAND AG (DE) | 2018-04-04 | — | — | EP | claimed |
| EP-2389403-A1 | POLYURETHANE SEALING COMPOUNDS | Bayer MaterialScience AG (DE) | 2011-11-30 | — | — | EP | claimed |
| US-20110281966-A1 | POLYURETHANE SEALING COMPOUNDS | COVESTRO DEUTSCHLAND AG (DE) | 2011-11-17 | — | — | US | claimed |
| US-20110257454-A1 | Use of an Additive in the Coupling of Toluene with a Carbon Source | FINA TECHNOLOGY, INC. (US) | 2011-10-20 | — | — | US | claimed |
| WO-2010083957-A1 | POLYURETHANE SEALING COMPOUNDS | BAYER MATERIALSCIENCE AG (DE) | 2010-07-29 | — | — | WO | claimed |
| US-12492281-B2 | Polyisocyanurate materials as electrical potting compounds | COVESTRO DEUTSCHLAND AG (DE) | 2025-12-09 | — | — | US | disclosed |
| CN-113201016-B | Preparation method of C15 phosphine salt | 万华化学集团股份有限公司 | 2023-09-19 | — | — | CN | disclosed |
| US-20230272151-A1 | STORAGE-STABLE POLYISOCYANATE COMPOSITION AND PREPARATION METHOD THEREFOR | WANHUA CHEMICAL GROUP CO., LTD. (CN) | 2023-08-31 | — | — | US | disclosed |
| US-6444778-B1 | DIISOCYANATES DIMERIZED USING TERTIARY PHOSPHINE CATALYST AND UREA OR AMIDE STABILIZERS; HIGH TEMPERATURE STORAGE STABLE CROSSLINKER FOR TWO-COMPONENT POLYURETHANE COATINGS | BAYER AKTIENGESELLSCHAFT (DE) | 2002-09-03 | — | — | US | disclosed |
| US-20020028930-A1 | Process for the production of uretdione polyisocyanates with improved monomer stability | BAYER AKTEINGESELLSCHAFT (DE) | 2002-03-07 | — | — | US | disclosed |
| EP-1174428-A2 | Process for the preparation of uretdione polyisocyanates with improved monomer stability | Bayer Aktiengesellschaft (DE) | 2002-01-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020028930-A1 | Process for the production of uretdione polyisocyanates with improved monomer stability | UROD, PUF60, UFM1 | EPHX1 2420/4885CYP2D6 2144/4885TP53 4405/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.